I reiterate a “Buy” rating on Agilent Technologies, Inc. with a one-year target price of $150 per share, driven by strategic ...

Q4 2024 Earnings Call Transcript November 25, 2024 Agilent Technologies, Inc. beats earnings expectations. Reported EPS is $1 ...

Throughout the last three months, 4 analysts have evaluated Agilent Technologies A +0.10% Get Free Report , offering a ...

Agilent (A – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Puneet Souda from Leerink Partners maintained a Buy rating on the stock and has ...

Medical equipment makers such as Agilent are seeing soft demand from early-stage biotechs, as these smaller drug development ...

In recent trading, Agilent Technologies Inc (A) stock price has shown some volatility, fluctuating 5.96% over the last five trades and 3.30% over the past 30 trades. This represents a notable shift ...

Agilent Technologies A reported fourth-quarter fiscal 2024 earnings of $1.46 per share, which beat the Zacks Consensus ...

Agilent Technologies announced reorganization into three business units: life sciences and diagnostics led by Simon May, ...

Stewart-Haas' sad demise belies its legacy of unlikely success (October 31, 2024, 7:00 PM ET) ...

Lockheed Martin has felt financial strain as early funding for the upcoming F-35 jets dried up, but kept working on them to avoid supply chain disruptions.

Netflix announced in April 2024 that it had officially ordered and put into production a new action thriller called Ad Vitam, which translates to To Life in English. The movie has since completed ...